Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
公司代码EMBC
公司名称Embecta Corp
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)
员工数量1850
证券类型Ordinary Share
年结日Mar 21
公司地址300 Kimball Drive
城市PARSIPPANY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07054
电话18624010000
网址https://www.embecta.com/
公司代码EMBC
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)